AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Ishras Investment Company Ltd.

Director's Dealing Sep 25, 2019

6866_dirs_2019-09-25_3bb58d59-1f59-4f58-a7a5-2654d1eb353e.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6764N

Merian Chrysalis Investment Co. Ltd

25 September 2019

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than the United Kingdom), Canada, Australia, Japan or the Republic of South Africa.

Merian Chrysalis Investment Company Limited

25 September 2019

Merian Chrysalis Investment Company Limited (the "Company")

Director Declaration

In compliance with Listing Rule 9.6.14, the Company announces that Mr Simon Holden, a Director of the Company, wishes to advise that the ordinary shares of JPMorgan Global Core Real Assets Limited, a company of which he is a Director, were admitted to trading on the Premium Listing Segment of the London Stock Exchange with effect from 24 September 2019.

There have been no other changes to the information set out in LR 9.6.13R (2) to LR 9.6.13R (6) in respect of Mr Holden.

For further information, please contact:

Merian Global Investors:

Amelie Shepherd
+44 (0) 20 7332 7500
Liberum:

Gillian Martin / Owen Matthews / Louis Davies
+44 (0) 20 3100 2000
Maitland Administration (Guernsey) Limited:

Aimee Gontier / Elaine Smeja
+44 (0) 1481 749364

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.merian.com/chrysalis/. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements.

Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal Prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

RDNLAMITMBMTBPL

Talk to a Data Expert

Have a question? We'll get back to you promptly.